Eximia Research-NC, LLC

Raleigh, North Carolina 27607

2 studies enrolling now · 8 studies all time

What they study most

Acute Migraine, Atrial Fibrillation (AF), COVID-19, Diabetes, Type 2, Major Depressive Disorder (MDD), Migraine, Obesity, Overweight, Overweight and/or Obesity, RSV Infection, SARS-COV-2 Infection, SARS-CoV-2

Studies at this site

• A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
• A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) — Running, not enrolling
• Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection — Stopped early
• A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19) — Running, not enrolling
• A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age — Running, not enrolling
• Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients — Completed
• WHOOP ECG Software Performance Assessment Study — Completed